Elizabeth Homans - Chief Executive Officer, Director at Lyell Immunopharma, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Executive Officer, Director
Stock Symbol
LYEL on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Elizabeth Homans since 7/8/2023

Holdings reported by Elizabeth Homans for Lyell Immunopharma, Inc.

Class Num Shares Value Price $ Report Date Ownership Underlying Class Underlying Amount
Option (right to buy) 1,479,500 Mar 16, 2022 Direct Common Stock

Transactions reported by Elizabeth Homans for Lyell Immunopharma, Inc.

Sym Class Transaction % Value $ Price $ Shares Shares After Date Ownership